EVERYONE DESERVES TO BE WELL

ARG is an oncology, immunology, rare and neurodegenerative disease-focused contract research organization with over 50 market authorizations.

THERAPEUTIC AREAS

SERVICES

Clinical
Operations

We Take On Partner Study Goals as our Goals

Medical Monitoring

From Start-up, We Act as an Extension of the Sponsor

Data
Management

We Set Expectations, Track Timelines And Measure Quality

Biostatistics

We Deliver Top Products and Services to our Clients

Drug
Safety

We Alleviate the Burden of Study Safety Reporting

Quality
Assurance

We Identify Challenges and Resolve Them Before Critical Stage

Systems Integration

Agility Allows Us to Ask Questions Tailored to Each Study

News & Highlights

Xtalks Webinar: How to Make Adaptive Dose-Finding Trials Easy for the Clinician

January 28, 2021

Atlantic Research Group will be presenting a webinar via Xtalks on Thursday March 11, 2021 at 11am EST. Please register here. Webinar Content Description: The drive to expedite arriving at

Press Release: Atlantic Research Group Opens Two New Global Offices

December 8, 2020

Locations in Switzerland and Australia Next Steps in Controlled Growth Plan CHARLOTTESVILLE, Va., STEINHAUSEN, Switzerland, and SYDNEY, Dec. 8, 2020 — Atlantic Research Group (ARG), a full-service global contract research

Press Release: Distinguished Researchers, Clinicians Join ARG in Advisory Roles

November 10, 2020

Drs. Schnipper, Stein and Genge Lead New Scientific Advisory Board CHARLOTTESVILLE, Va., Nov. 10, 2020 — Atlantic Research Group (ARG), a global full-service contract research organization, named three leading scientists